| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jamia/BackusGLHPBM09 |
| P356 | DOI | 10.1197/JAMIA.M3203 |
| P932 | PMC publication ID | 3002122 |
| P698 | PubMed publication ID | 19717794 |
| P50 | author | Lisa I Backus | Q42285340 |
| P2093 | author name string | Barbara R Phillips | |
| James P Halloran | |||
| Larry A Mole | |||
| Pamela S Belperio | |||
| Sergey Gavrilov | |||
| Timothy P Loomis | |||
| P2860 | cites work | Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease | Q46812247 |
| Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods | Q73208180 | ||
| Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic | Q81230799 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions | Q28384344 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Electronic Support for Public Health: validated case finding and reporting for notifiable diseases using electronic medical data | Q33379561 | ||
| The Immunology Case Registry | Q34466535 | ||
| The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients | Q35550247 | ||
| VistA--U.S. Department of Veterans Affairs national-scale HIS. | Q38465088 | ||
| Use of electronic health records in U.S. hospitals | Q39879070 | ||
| Building a comprehensive clinical information system from components. The approach at Intermountain Health Care | Q40594056 | ||
| Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus | Q43033701 | ||
| Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy | Q44836883 | ||
| Electronic patient registries improve diabetes care and clinical outcomes in rural community health centers | Q44944645 | ||
| Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs | Q45331502 | ||
| Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability | Q45331701 | ||
| Predictors of response of US veterans to treatment for the hepatitis C virus | Q45332298 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 775-783 | |
| P577 | publication date | 2009-08-28 | |
| P1433 | published in | Journal of the American Medical Informatics Association | Q152037 |
| P1476 | title | Clinical Case Registries: simultaneous local and national disease registries for population quality management | |
| P478 | volume | 16 |
| Q34301401 | A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans |
| Q98892424 | Accelerating the elimination of hepatitis C in Kuwait: An expert opinion |
| Q39818571 | Achieving a Nationwide Learning Health System |
| Q36445942 | Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients |
| Q50684913 | Assessment of electronic health information system use and need in US adult congenital heart disease centers. |
| Q35858493 | Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans |
| Q42251563 | Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection |
| Q36100706 | Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. |
| Q37077982 | Association of tenofovir exposure with kidney disease risk in HIV infection |
| Q37542914 | Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons |
| Q56893596 | Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration |
| Q34577157 | Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients |
| Q28603024 | Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource |
| Q39690146 | Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice. |
| Q33411348 | Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort |
| Q34173349 | Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans |
| Q35850889 | Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients |
| Q47644014 | Direct-Acting Antiviral Sustained Virologic Response: Impact on Mortality in Patients without Advanced Liver Disease |
| Q33587514 | Dispelling myths about rare disease registry system development |
| Q35009761 | Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma |
| Q40335100 | Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice |
| Q40795101 | Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans. |
| Q39867681 | Epidemiology and outcomes of hepatitis C infection in elderly US Veterans |
| Q30366707 | Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA. |
| Q40182606 | Geographic access and use of infectious diseases specialty and general primary care services by veterans with HIV infection: implications for telehealth and shared care programs |
| Q36399139 | HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. |
| Q42205680 | HIV quality report cards: impact of case-mix adjustment and statistical methods. |
| Q37380420 | Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey |
| Q38014990 | Identifying newly acquired cases of hepatitis C using surveillance: a literature review |
| Q40117313 | Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease |
| Q43042118 | Implications of rapid virological response in hepatitis C therapy in the US veteran population |
| Q43001380 | Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study |
| Q34777639 | Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection |
| Q35435112 | Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma |
| Q88115444 | Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans |
| Q43571174 | Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection |
| Q37305565 | Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease |
| Q37060330 | Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients |
| Q38323723 | Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs |
| Q47330339 | Process of care for hepatitis C infection is linked to treatment outcome and virologic response |
| Q34173588 | Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans |
| Q36813322 | Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults |
| Q42203327 | Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans |
| Q41707948 | Rapid Development of Specialty Population Registries and Quality Measures from Electronic Health Record Data*. An Agile Framework |
| Q39821108 | Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients |
| Q33716634 | Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors |
| Q36006322 | Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study |
| Q42980919 | Results from a large-scale epidemiologic look-back investigation of improperly reprocessed endoscopy equipment |
| Q36693929 | Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population |
| Q37029846 | Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection |
| Q37228611 | Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system |
| Q35111633 | Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection |
| Q33631163 | Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans |
| Q39796563 | Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study |
| Q40588764 | Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals |
| Q40501796 | Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals |
| Q36505496 | Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. |
| Q33693566 | Surveillance for Hepatocellular Carcinoma: Development and Validation of an Algorithm to Classify Tests in Administrative and Laboratory Data |
| Q36746411 | Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans |
| Q91599086 | The State of Hepatitis C Care in the VA |
| Q35102095 | The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection |
| Q38716514 | The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. |
| Q39589157 | The performance of process measures in hepatitis C. |
| Q28741319 | Trends in biomedical informatics: most cited topics from recent years |
| Q35715660 | Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection |
Search more.